Clinical Trial Update: Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a combination of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with previously treated lymphoid malignancies; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma
• Angioimmunoblastic T-cell Lymphoma
• Cutaneous B-cell Non-hodgkin Lymphoma
• Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
• Extranodal Nk T-cell Lymphoma Nasal Type
• Follicular Lymphoma
• Hepatosplenic T-cell Lymphoma
• Mantle Cell Lymphoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DEXAMETHASONE (Dexamethasone)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• Rituximab (rituximab)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2017-06-29